1. Oral tetrahydroaminoacridine in long-tcrm treatment of senile dementia, Alzheimer's type;Pirrozzolo, F.J.; Baskin, D.S.; Swihart, A.A.; Appel, S.H.;N EnglJ7 Med,1987
2. Tetrahvdroaminoacridine in Alzheimer's disease: a double-blind pilot study;Lacomblez, L.; Chatellier, G.; Rapin, JR, LePoncin; M, Derouesnd; C.;Fundam Clin Pharmacol,1989
3. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-AD)RDA working group under the auspices of health and human services task force on Alzheimer's disease;McKhann, G.; Drachman, D.; Folstein, M.; Katzman, R.; Price, D.; Stadlan, E.M.;Neurology,1984
4. Cerebral blood flow in dementia;Hachinski, V.C.; Iliff, L.D.; Zilkha, E.;Arch Neurol,1975
5. Diagnostic and statistical manual of mental dis(wrders, third edition;Association, American Psychiatric,1987